|
Volumn 172, Issue , 1998, Pages 106-109
|
Which atypical antipsychotic.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NEUROLEPTIC AGENT;
COST BENEFIT ANALYSIS;
DECISION MAKING;
DRUG RESISTANCE;
ECONOMICS;
EDITORIAL;
HOSPITAL COST;
HUMAN;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
ANTIPSYCHOTIC AGENTS;
COST-BENEFIT ANALYSIS;
DECISION MAKING;
DRUG RESISTANCE;
HOSPITAL COSTS;
HUMANS;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
|
EID: 0031992394
PISSN: 00071250
EISSN: None
Source Type: Journal
DOI: 10.1192/bjp.172.2.106 Document Type: Editorial |
Times cited : (51)
|
References (0)
|